View of EARLY DIAGNOSTICS OF DISORDERS OF THE NEUROMEDIATOR SYSTEMS WITH THE USE OF NEUROTROPIC AUTOANTIBODIES IN PERSONS WITH COVID-19

Return to Article Details EARLY DIAGNOSTICS OF DISORDERS OF THE NEUROMEDIATOR SYSTEMS WITH THE USE OF NEUROTROPIC AUTOANTIBODIES IN PERSONS WITH COVID-19 Download Download PDF